InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Howell Peyton R. Director active across 2 companies, notably TANDEM DIABETES CARE INC. Aggregated, 9 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €91k. Activity tracked since 3 August 2021. The latest transaction was filed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Howell Peyton R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
4,387 shares@ US$20.6421.0% of flowCommon StockSEC:0001438133-25-000105:0
4,434 shares@ US$51.7355.4% of flowCommon StockSEC:0001438133-24-000126:0
949 shares0Common StockSEC:0001438133-23-000157:0
2,757 shares0Common StockSEC:0001438133-23-000106:0
3,000 shares@ US$30.16421.8% of flowCommon StockSEC:0001438133-23-000090:0
Canonical exit: 15 Aug 2023 (T+90)
949 shares0Common StockSEC:0001438133-22-000183:0
1,653 shares0Common StockSEC:0001438133-22-000097:0
100 shares@ US$75.20971.9% of flowCommon StockSEC:0001438133-22-000067:0
Canonical exit: 4 Aug 2022 (T+90)
948 shares0Common StockSEC:0001438133-21-000123:0
9 of 9 declarations
About Howell Peyton R
Howell Peyton R is a declarant and a Director at Tandem Diabetes Care INC, with 9 filings in total. In the 9 most recent sampled filings, the total buy amount is EUR 90628, the total sell amount is EUR 0, the date range runs from 2021-08-05 to 2025-05-23, and the most common transaction nature is Option exercise.
